SMTL ID : 5pgz.1

CRYSTAL STRUCTURE OF MURINE 11BETA- HYDROXYSTEROIDDEHYDROGENASE COMPLEXED WITH 2-[(5R,7S)-6-HYDROXY-2-PHENYLADAMANTAN-2-YL]-1-(3-HYDROXYAZETIDIN-1-YL)ETHAN-1-ONE (BMS-816336)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 31 residues within 4Å: Chain A: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, E.78, N.103, H.104, I.105, T.106, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 Ligands: 8KG.2 26 PLIP interactions: 26 interactions with chain A Hydrophobic interactions: A:L.199 Hydrogen bonds: A:S.27, A:S.27, A:S.27, A:K.28, A:K.28, A:K.28, A:I.30, A:G.31, A:R.50, A:S.51, A:T.76, A:M.77, A:I.105, A:Y.131, A:I.152, A:Y.167, A:K.171, A:I.202, A:T.204, A:T.204, A:T.206 Water bridges: A:I.105 Salt bridges: A:K.28, A:K.28, A:R.50 NAP.6: 31 residues within 4Å: Chain B: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, E.78, N.103, H.104, I.105, T.106, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 Ligands: 8KG.7 21 PLIP interactions: 21 interactions with chain B Hydrophobic interactions: B:L.199 Hydrogen bonds: B:S.27, B:S.27, B:S.27, B:K.28, B:K.28, B:K.28, B:I.30, B:G.31, B:R.50, B:S.51, B:T.76, B:M.77, B:I.105, B:I.152, B:K.171, B:I.202, B:T.204 Salt bridges: B:K.28, B:K.28, B:R.50

2 x 8KG: 2-[(5R,7S)-6-HYDROXY-2-PHENYLADAMANTAN-2-YL]-1-(3-HYDROXYAZETIDIN-1-YL)ETHAN-1-ONE(Non-covalent)

8KG.2: 18 residues within 4Å: Chain A: I.105, T.108, L.110, S.154, L.155, A.156, Q.161, I.164, Y.167, L.199, G.200, L.201, A.207, E.210, I.211, I.215 Chain B: Y.268 Ligands: NAP.1 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.110, A:L.110, A:I.164, A:Y.167, A:Y.167, A:L.201, A:A.207, A:E.210, A:I.211, A:I.215 Hydrogen bonds: A:T.108, A:S.154, A:Q.161, A:L.201 8KG.7: 18 residues within 4Å: Chain A: Y.268 Chain B: I.105, T.108, L.110, S.154, L.155, A.156, Q.161, I.164, Y.167, L.199, G.200, L.201, A.207, E.210, I.211, I.215 Ligands: NAP.6 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:L.110, B:L.110, B:I.164, B:Y.167, B:A.207, B:E.210, B:I.211, B:I.215 Hydrogen bonds: B:T.108, B:S.154, B:Q.161, B:Y.167, B:L.201

5 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 7 residues within 4Å: Chain A: K.28, G.29, R.32, T.204, E.205, T.206, K.222 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.29, A:E.205, A:T.206 Salt bridges: A:R.32, A:K.222 SO4.4: 2 residues within 4Å: Chain A: R.50, Q.107 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.107 Salt bridges: A:R.50 SO4.5: 3 residues within 4Å: Chain A: K.237, S.238, E.239 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.238, A:S.238, A:E.239 Salt bridges: A:K.237 SO4.8: 7 residues within 4Å: Chain B: K.28, G.29, R.32, T.204, E.205, T.206, K.222 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:G.29, B:E.205, B:T.206, B:T.206 Salt bridges: B:R.32, B:K.222 SO4.9: 3 residues within 4Å: Chain B: K.237, S.238, E.239 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.238, B:E.239

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ye, X.Y. et al., Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor. J. Med. Chem. (2017)

Release Date

2017-11-01

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence